Cyanosis primary prevention: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Cyanosis}}
{{Cyanosis}}
Please help WikiDoc by adding content here. It's easy!  Click  [[Help:How_to_Edit_a_Page|here]] to learn about editing.
{{CMG}}; {{AE}}
 
==Overview==
There are no established measures for the primary prevention of [disease name].
 
OR
 
There are no available vaccines against [disease name].
 
OR
 
Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3].
 
OR
 
[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include [strategy 1], [strategy 2], and [strategy 3].
 
==Primary Prevention==
*There are no established measures for the primary prevention of [disease name].
*There are no available vaccines against [disease name].
OR
*Effective measures for the primary prevention of [disease name] include:
**[Measure1]
**[Measure2]
**[Measure3]
OR
*[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include:
**[Strategy 1]
**[Strategy 2]
**[Strategy 3]
 
 
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}


[[Category:Needs content]]
{{WH}}
[[Category:Dermatology]]
{{WS}}
[[Category:Cardiology]]
[[Category:Physical Examination]]
[[Category:Pulmonology]]

Revision as of 17:26, 19 February 2018

Cyanosis Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cyanosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cyanosis primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cyanosis primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cyanosis primary prevention

CDC on Cyanosis primary prevention

Cyanosis primary prevention in the news

Blogs on Cyanosis primary prevention

Directions to Hospitals Treating Cyanosis

Risk calculators and risk factors for Cyanosis primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

There are no established measures for the primary prevention of [disease name].

OR

There are no available vaccines against [disease name].

OR

Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3].

OR

[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include [strategy 1], [strategy 2], and [strategy 3].

Primary Prevention

  • There are no established measures for the primary prevention of [disease name].
  • There are no available vaccines against [disease name].

OR

  • Effective measures for the primary prevention of [disease name] include:
    • [Measure1]
    • [Measure2]
    • [Measure3]

OR

  • [Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include:
    • [Strategy 1]
    • [Strategy 2]
    • [Strategy 3]


References

Template:WH Template:WS